A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patientswith Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib

Project: Research project

Project Details

Description

A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib
StatusActive
Effective start/end date12/1/181/30/22

Funding

  • DECIPHERA PHARMACEUTICALS, LLC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.